Passive Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$671K Buy
730
+20
+3% +$20.3K 0.2% 45
2025
Q4
$763K Buy
710
+8
+1% +$7.65K 0.24% 43
2025
Q3
$536K Sell
702
-11
-2% -$8.19K 0.17% 53
2025
Q2
$553K Hold
713
0.17% 49
2025
Q1
$589K Sell
713
-5
-0.7% -$4.16K 0.19% 45
2024
Q4
$554K Hold
718
0.2% 41
2024
Q3
$636K Hold
718
0.22% 37
2024
Q2
$650K Buy
+718
New +$574K 0.24% 36
2022
Q3
Sell
-648
Closed -$210K 50
2022
Q2
$210K Buy
+648
New +$195K 0.11% 49

Other funds holding LLY

Passive Capital Management's LLY Position: Q1 2026 in Review

Passive Capital Management increased its Eli Lilly (LLY) stake by 2.8% in Q1 2026, buying an estimated $20.3K and bringing the position to 730 shares worth $671K. The position accounts for 0.2% of the portfolio, ranked #45.

Passive Capital Management first reported a position in LLY in Q2 2022 and has held it in 9 quarters since. The position peaked at $763K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Passive Capital Management held 730 shares of Eli Lilly worth $671K as of Q1 2026.
  • Passive Capital Management bought 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
  • Eli Lilly made up 0.2% of Passive Capital Management's portfolio in Q1 2026, its #45 holding.
  • Passive Capital Management first reported a position in Eli Lilly in Q2 2022 and has held it in 9 quarters since.
  • Passive Capital Management's Eli Lilly position peaked at $763K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Passive Capital Management's 13F filing for Q1 2026, filed 14 May 2026.